Norihiko Ikeda

Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.

S. Oizumi, Y. Ohde, K. Takamochi, 2023, Cancer science.

Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809

M. Tsuboi, Y. Hosomi, N. Ikeda, 2013, British Journal of Cancer.

NOTCH1 and CREBBP co‐mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR‐mutated NSCLC: translational research of phase III IMPACT study

Y. Ohde, H. Akamatsu, H. Tada, 2023, Molecular oncology.

Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients with Driver Mutations

M. Nishio, H. Ninomiya, S. Okumura, 2024, Cancers.